DMCPA, also known as 2,5-dimethoxy-4-methylphenylcyclopropylamine, is a psychedelic drug of the phenethylamine, amphetamine, and phenylcyclopropylamine families related to DOM. It is a derivative of tranylcypromine and is the cyclized phenethylamine analogue of DOM in which the ñ and ò positions have been connected with a carbon atom to form a cyclopropyl group.
In Alexander Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved), the dose range is listed as 15 to 20mg and the duration is listed as 4 to 8hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. One of the reports in PiHKAL gave it a +++ on the Shulgin Rating Scale.
The comprehensive receptor interactions of DMCPA have been studied.
The chemical synthesis of DMCPA has been described.
DMCPA was first described in the scientific literature by at least 1974.
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.